{"id":"NCT01658020","sponsor":"Dong Wha Pharmaceutical Co. Ltd.","briefTitle":"A Study to Evaluate Efficacy and Safety Profile of Zabofloxacin Tablet 400mg and Moxifloxacin Tablet 400mg","officialTitle":"Clinical Trials to Evaluate Efficacy and Safety of Zabofloxacin Tablet 400mg and Moxifloxacin Tablet 400mg After Multi-dose Oral Administration in Patients With Acute Bacterial Exacerbation of Chronic Obstructive Pulmonary Disease.","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2012-08","primaryCompletion":"2014-01","completion":"2014-08","firstPosted":"2012-08-06","resultsPosted":"2014-09-17","lastUpdate":"2014-10-13"},"enrollment":345,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"TRIPLE","primaryPurpose":"TREATMENT"},"conditions":["Chronic Obstructive Pulmonary Disease"],"interventions":[{"type":"DRUG","name":"Zabofloxacin","otherNames":["DW224"]},{"type":"DRUG","name":"Moxifloxacin","otherNames":["Avelox"]}],"arms":[{"label":"DW224","type":"EXPERIMENTAL"},{"label":"Avelox","type":"ACTIVE_COMPARATOR"}],"summary":"The purpose of this study is to Evaluate the Efficacy and Safety Profiles of oral multiple dose of Zabofloxacin Tablet 400 mg.","primaryOutcome":{"measure":"Clinical Response in the Clinical Populations","timeFrame":"10days","effectByArm":[{"arm":"DW224","deltaMin":86.71,"sd":null},{"arm":"Avelox","deltaMin":86.26,"sd":null}],"pValues":[]},"eligibility":{"minAge":"40 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":6,"exclusionCount":16},"locations":{"siteCount":1,"countries":["South Korea"]},"refs":{"pmids":["31920016"],"seeAlso":["http://medical.amc.seoul.kr/medservice/main/main.do","http://www.dong-wha.co.kr/dw_main.asp"]},"adverseEventsSummary":{"seriousAny":{"events":0,"n":175},"commonTop":["Nausea","Diarrhoea","Dizziness","Headache","Chest discomfort"]}}